Andreas Jönsen

Andreas Jönsen

UNVERIFIED PROFILE

Are you Andreas Jönsen?   Register this Author

Register author
Andreas Jönsen

Andreas Jönsen

Publications by authors named "Andreas Jönsen"

Are you Andreas Jönsen?   Register this Author

58Publications

1187Reads

-Profile Views

Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus.

J Comp Neurol 2019 Aug 19;527(11):1837-1856. Epub 2019 Feb 19.

Division of Clinical Radiology, Department of Clinical Sciences, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cne.24656DOI Listing
August 2019

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Smoking reduces the efficacy of belimumab in mucocutaneous lupus.

Expert Opin Biol Ther 2018 08 9;18(8):911-920. Epub 2018 Jul 9.

a Division of Rheumatology, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2018.1494719DOI Listing
August 2018

Functional Connectivity Changes in Systemic Lupus Erythematosus: A Resting-State Study.

Brain Connect 2018 05 5;8(4):220-234. Epub 2018 Apr 5.

7 Department of Clinical Sciences , Lund/Memory Research Unit, Lund University, Lund, Sweden .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/brain.2017.0557DOI Listing
May 2018

Altered white matter microstructure in lupus patients: a diffusion tensor imaging study.

Arthritis Res Ther 2018 02 7;20(1):21. Epub 2018 Feb 7.

Department of Clinical Sciences Lund/Diagnostic Radiology, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1516-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803933PMC
February 2018

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.

Arthritis Res Ther 2017 Dec 6;19(1):266. Epub 2017 Dec 6.

Department of Translational Medicine, Section of Medical Protein Chemistry, Lund University, Inga Marie Nilsson's Street 53, 205 02, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-017-1470-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717799PMC
December 2017

A single nucleotide polymorphism in the gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Ann Rheum Dis 2017 Sep 12;76(9):1607-1613. Epub 2017 Jun 12.

Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211287DOI Listing
September 2017

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.

Autoimmun Rev 2017 Apr 13;16(4):343-351. Epub 2017 Feb 13.

Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.02.005DOI Listing
April 2017

Case definitions in Swedish register data to identify systemic lupus erythematosus.

BMJ Open 2016 Jan 4;6(1):e007769. Epub 2016 Jan 4.

Clinical Epidemiology Unit, Department of Medicine, Solna Karolinska Institute, Stockholm, Sweden Division of Epidemiology, Department of Health Research and Policy, Stanford School of Medicine, Stanford, California, USA Division of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-007769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716148PMC
January 2016

Systemic lupus erythematosus prevalence in Sweden in 2010: what do national registers say?

Arthritis Care Res (Hoboken) 2014 Nov;66(11):1710-7

Karolinska Institutet, Stockholm, Sweden; Stanford School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22355DOI Listing
November 2014

Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

Rheumatology (Oxford) 2013 Nov 13;52(11):2048-55. Epub 2013 Aug 13.

Department of Clinical Sciences, Division of Rheumatology, Lund University, SE-221 85 Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket263DOI Listing
November 2013

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.

Rheumatology (Oxford) 2011 Jun 28;50(6):1064-9. Epub 2011 Jan 28.

Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keq459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093930PMC
June 2011

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.

Arthritis Res Ther 2011 Apr 15;13(2):R62. Epub 2011 Apr 15.

Department of Laboratory Medicine, Section of Clinical Chemistry, Lund University, Wallenberg Laboratory, Skåne University Hospital, Södra Förstadsgatan 101, Malmö, SE 205 02, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar3316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132057PMC
April 2011

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

Blood 2010 Sep 10;116(11):1951-7. Epub 2010 Jun 10.

Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University Hospital, Sölvegatan 23, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-03-274605DOI Listing
September 2010

Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.

J Rheumatol 2008 Oct 1;35(10):1994-2000. Epub 2008 Sep 1.

Division of Rheumatology, Autoimmunity and Immune Regulation unit (AIR) and Department of Clinical and Experimental Medicine, Faculty of Health Science, Linköping University, Linköping University Hospital, Linköping, Sweden.

View Article

Download full-text PDF

Source
October 2008

Gene-environment interactions in the aetiology of systemic lupus erythematosus.

Autoimmunity 2007 Dec;40(8):613-7

Section of Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08916930701511051DOI Listing
December 2007